Antimicrobial susceptibilities of aerobic and facultative gram-negative bacilli isolated from Chinese patients with urinary tract infections between 2010 and 2014
Qiwen Yang,Hui Zhang,Yao Wang,Zhipeng Xu,Ge Zhang,Xinxin Chen,Yingchun Xu,Bin Cao,Haishen Kong,Yuxing Ni,Yunsong Yu,Ziyong Sun,Bijie Hu,Wenxiang Huang,Yong Wang,Anhua Wu,Xianju Feng,Kang Liao,Yanping Luo,Zhidong Hu,Yunzhuo Chu,Juan Lu,Jianrong Su,Bingdong Gui,Qiong Duan,Shufang Zhang,Haifeng Shao,Robert E. Badal
DOI: https://doi.org/10.1186/s12879-017-2296-x
IF: 3.7
2017-01-01
BMC Infectious Diseases
Abstract:Background The objective of this study was to investigate the distribution and susceptibility of aerobic and facultative Gram-negative bacilli isolated from Chinese patients with UTIs collected within 48 h (community acquired, CA) or after 48 h (hospital acquired, HA) of hospital admission. Methods From 2010 to 2014, the minimum inhibitory concentrations (MICs) of 12 antibiotics for 4,332 aerobic and facultative Gram-negative bacilli, sampled in 21 hospitals in 16 cities, were determined by the broth microdilution method. Results Enterobacteriaceae composed 88.5% of the total isolates, with Escherichia coli ( E. coli ) (63.2%) the most commonly isolated species, followed by Klebsiella pneumoniae ( K. pneumoniae ) (12.2%). Non- Enterobacteriaceae accounted for only 11.5% of all isolates and included mainly Pseudomonas aeruginosa ( P. aeruginosa ) (6.9%) and Acinetobacter baumannii ( A. baumannii ) (3.3%). Among the antimicrobial agents tested, the susceptibility rates of E.coli to the two carbapenems, ertapenem and imipenem as well as amikacin and piperacillin-tazobactam ranged from 92.5 to 98.7%. Against K. pneumonia, the most potent antibiotics were imipenem (92.6% susceptibility), amikacin (89.2% susceptibility) and ertapenem (87.9% susceptibility). Although non- Enterobacteriaceae did not show high susceptibilities to the 12 common antibiotics, amikacin exhibited the highest in vitro activity against P. aeruginosa over the 5-year study period, followed by piperacillin-tazobactam, imipenem, ceftazidime, cefepime, ciprofloxacin, and levofloxacin. The Extended Spectrum Beta-Lactamase (ESBL) rates decreased slowly during the 5 years in E. coli from 68.6% in 2010 to 59.1% in 2014, in K. pneumoniae from 59.7 to 49.2%, and in Proteus mirabilis ( P. mirabilis ) from 40.0 to 26.1%. However, the ESBL rates were different in 5 regions of China (Northeast, North, East, South and Middle-China). Conclusion E. coli and K. pneumonia were the major pathogens causing UTIs and carbapenems and amikacin retained the highest susceptibility rates over the 5-year study period, indicating that they are good drug choices for empirical therapies, particularly of CA UTIs in China.